On the immune cell side, it has been demonstrated that FLASH-RT promotes better recruitment of CD3+ T cells to the tumor core compared to CONVi, as well as higher levels of cytotoxic CD8α+ T cells in the TME (108). This evidence concerns the gene CD8A and neoplasm.